Olshansky, B., Bhatt, D. L., Miller, M., Steg, Ph. G., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Doyle, R. T., Juliano, R. A., Jiao, L., Kowey, P. R., Reiffel, J. A., Tardif, J., Ballantyne, C. M., & Chung, M. K. (2023). Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE‐IT. Journal of the American Heart Association, 12(5). https://doi.org/10.1161/jaha.121.026756